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Experimental Ultrasonic Angioplasty: Disruption of Atherosclerotic 
Plaques and Thrombi in Vitro and Arterial Recanalization in Vivo 
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To investigate the use of high energy ultrasound as an 
alternative energy for angioplasty, an experimental ultra- 
sonic angioplasty device was developed. The device was 
studied in two bioassay systems: an in vitro system for the 
disruption of atherosclerotic plaques and thrombi and an in 
vivo system for the recanalization of occluded canine fem- 
oral arteries. 
In vitro, sonication efficiently reduced the size of the 
plaques. Atheromatous plaques (n = 11) disrupted at a 
rate of 21 2 8 s/cm’; complicated plaques (n = 14) 
disrupted at a rate of 132 it 45 s/cm’ (p < 0.001). Histo- 
logic examination revealed that the disruption of the 
plaques took place without concurrent damage to the 
media or adventitia. Ninety percent of the disrupted 
plaque debris had a diameter of ~20 pm and was 
composed primarily of cholesterol monohydrate crys- 
tals. Solid thrombus (n = 5) weight was reduced from 
Atherosclerosis is a leading cause of morbidity and mortality 
in the western world. The development of the balloon 
catheter by Gruentzig et al. (1,2) heralded a new era in the 
catheter-based interventional approach to arterial obstruc- 
tive diseases. Angioplasty is currently based on balloon 
dilation. Recently, alternative angioplasty techniques have 
been devised, including various laser-based systems, vascu- 
lar stents and atherectomy devices (3-8). 
In the present study, we investigated the use of high 
energy, 20 kHz ultrasound as an alternative energy for 
angioplasty. Twenty kHz ultrasound has been used in vitro 
for >20 years to disrupt tissues for research purposes (9-11). 
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1.6 + 0.2 to 0.4 f 0.1 g (p < 0.0001) after 20 s of 
sonication. 
In vivo, sonication resulted in recanalization in all seven 
arteries tested in seven dogs. The obstruction was reduced 
from 93 5 11% to 18 -C 7% (p < 0.001). On histologic 
examination, the arterial wall injury index was found to be 
1.56 1 0.42 in the test arteries compared with 1.37 + 0.47 
in the control arteries (p = NS). 
The disruption of atherosclerotic plaques and thrombi, 
together with the efficient recanalization of the occluded 
arteries, demonstrates the potential of ultrasound angio- 
plasty as a catheter-based technique for angioplasty. The 
histologic findings suggest that the ultrasonic angioplasty 
device selectively disrupts the ultrasound-sensitive athero- 
sclerotic plaques and thrombi, with minimal damage to the 
ultrasound-resistant arterial wall. 
(.I Am Co11 Cardiol1990;15:711-7) 
In the last decade, 20 kHz ultrasound has been employed 
clinically to disintegrate renal and urethra1 calculi, in surgery 
with the ultrasound scalpel and for aortic valve decalcifica- 
tion (12-15). The experience gained by using high energy, 20 
kHz ultrasound has revealed that tissues display a spectrum 
of susceptibility to ultrasonic disruption. Tissues heavily 
embedded with collagen and elastin matrix, such as arteries, 
aortic valve and bladder, are especially resistant to ultra- 
sound. Tissues lacking the normal collagen and elastin fiber 
support, such as atherosclerotic plaques (16,17), fat and 
calcific deposits on the aortic valve, are especially suscepti- 
ble to ultrasonic disruption. 
We posited that ultrasound would be an idea1 energy 
to be employed for angioplasty, being able to disrupt 
plaques and thrombi with a large safety margin before 
damaging the arterial wall. Other energy forms employed 
for angioplasty (namely, thermal, electromagnetic or me- 
chanical) are all nonselective energy forms capable of 
damaging the arterial wall. The experimental ultrasonic 
angioplasty device described here was developed to guide 
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Figure 1. Schematic drawing of the ultrasonic angioplasty device. 
the ultrasound in a flexible delivery system to the target 
tissue. 
Methods 
Ultrasonic angioplasty device. An experimental angio- 
plasty device capable of guiding high energy ultrasound into 
the arterial system in a flexible delivery system was devel- 
oped (U. Rosenschein and J. Bernstein, U.S. patent pend- 
ing) (Fig. 1). The device consists of a flexible solid ultra- 
sound transmission wire attached at its proximal end to a 
piezoelectric element, which with acoustic resonators is 
capable of vibrating at 20 kHz. The device is powered by an 
external generator (Sonifier, model 250, Branson Ultrasonics 
Corporation). The ultrasound energy is transformed into 
longitudinal vibrations of the ultrasound wire that guides the 
energy into the arterial system. The distal end of the ultra- 
sound wire vibrates longitudinally, with an amplitude of 
150 ? 25 pm, as measured by an amplitude tester (Amplitude 
Tester, model A455, Branson Ultrasonics Corporation). The 
ultrasound generator was operated in the pulsed mode with 
a 30% duty cycle (pulse width 300 ms, period 1,000 ms) to 
guarantee resonance capture of the ultrasound wire’s longi- 
tudinal resonant mode. 
Heat generated by the ultrasound wire was measured 
calorimetrically. An ultrasound wire (length 25 cm, diameter 
1 mm) was immersed in a thermally isolated water bath 
(volume 25 ml, temperature 25 ? O.OS”C) and powered for 
240 s. Water temperature was constantly monitored (Tem- 
perature Monitor, model 43TD and Thermoprobe, model 
YSI-Series 400, Yellowsprings Instruments Corporation). 
The monitor detected no change in the water temperature, 
indicating that temperature change in the ultrasound wire 
could not have exceeded 10°C. Wire diameter of 1 mm and 
lengths of up to 30 cm were used. 
In Vitro Ultrasound Disruption Studies 
To test the ability of the ultrasonic angioplasty device to 
transmit biologically effective levels of ultrasound, the dis- 
ruption of the two components in arterial obstructive disease 
was studied: atherosclerotic plaque and thrombus. 
Atherosclerotic plaque disruption. Aortic segments (n = 
3 1) were obtained from individuals (n = 26) during postmor- 
tem examination. The aortic segments were dissected within 
24 h of the patient’s death and stored in 0.9% saline solution 
at 4°C for <24 h. The atherosclerotic segments (n = 25) were 
divided according to gross examination into atheromatous 
(n = 11) and complicated (n = 14) plaques (18). The 
remaining segments (n = 6) were healthy control segments. 
Each segment was opened longitudinally. The ultrasound 
wire was manually positioned perpendicular to the arterial 
wall without bending, with its distal tip in direct contact with 
the target tissue. No arterial wall perforation or plaque 
penetration was noted as a result of applied force without 
sonication. 
During application of ultrasound (power 20 & 10 W), the 
contact area was irrigated with a sufficient flow of saline 
solution to maintain ultrasonic coupling (that is, to prevent 
an air gap between the ultrasound wire tip and the artery). In 
the atherosclerotic segments, sonication was continued 
while the distal tip of the ultrasound wire was passed 
manually over the plaque until it had been entirely disrupted 
or had ceased to decrease in size. The relative susceptibili- 
ties to ultrasound of the atheromatous and complicated 
plaques was evaluated by measuring their rate of disruption, 
defined as the time required to disrupt 1 cm2 of plaque. The 
control arterial segments were exposed to 240 s of sonication 
at the same power level. 
All segments exposed to ultrasound were placed in 10% 
neutral formalin. After fixation, 2 mm serial cross sections 
of the arterial wall were embedded in paraffin, and 5 pm 
sections were stained with hematoxylin-eosin and Verhoeff- 
van Gieson elastin stains. Histologic examination was per- 
formed with special attention to the disrupted plaque and the 
adjacent arterial wall morphology. 
Thrombus disruption. Whole blood thrombi (n = 10) 
were formed by allowing 2.5 ml of venous blood to coagulate 
in a glass test tube (12 x 95 mm) for 30 min. The thrombus 
was centrifuged for 3 min at 500 g; the solid thrombus was 
separated from the serum and weighed. In the test thrombi 
(n = 5), the distal tip of the ultrasound wire was inserted into 
the thrombus. Ultrasound (power 20 * 10 W) was then 
applied for 20 s. During sonication, the ultrasound wire was 
moved back and forth through the thrombus two or three 
times. In the control thrombi (n = 5), the same procedure 
was followed but without sonication. The thrombi, both test 
and control, were then centrifuged for 3 min at 500 g. The 
solid thrombi were separated from the supernatant and 
weighed. The susceptibility of the thrombi to ultrasound was 
evaluated by measuring their rate of disruption; this was 
defined as the reduction in solid thrombus weight after 20 s 
of sonication. 
Fibrin thrombi (n = 10) were formed by adding thrombin 
(3 NIH units, Thrombin Reagent, Merz-Dade) to 3 ml of 
titrated plasma and allowing the plasma to coagulate for 
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5 min. The distal tip of the ultrasound wire was inserted into 
the thrombus. In the test thrombi (n = 5), ultrasound (power 
20 f 10 W) was applied for 20 s. During sonication, the 
ultrasound wire was moved back and forth through the 
thrombus two or three times. In the control thrombi (n = 5), 
the same procedure was followed but without sonication. 
The supernatants were separated and tested for the presence 
of fibrinogen/fibrin degradation products by using the Dade 
FDP Detection Kit (American Dade). 
Microscopic studies. The irrigating saline solution from 
sonicated atheromatous plaques (n = 9) and the supernatant 
from the sonicated thrombi (n = 5) were studied using light, 
polarized light and contrast phase microscopy (Photomicro- 
scope, Carl-Zeiss) to characterize sonicated plaque debris 
shape and composition. The supernatants were examined for 
the presence of fibrin fragments and changes in red blood cell 
morphology. Debris particle size measurements were ef- 
fected by use of a calibrated eyepiece micrometer. Debris 
particle size was classified as >20 pm or ~20 pm. 
In Vivo Ultrasound Rrcanalization Studies 
Experimental preparation. The ability of the ultrasonic 
angioplasty device to transmit biologically effective levels of 
ultrasound was examined by recanalizing occluded canine 
femoral arteries. Following the guidelines set for animal 
research by the American Physiological Society, seven adult 
mongrel dogs, weighing 20 to 35 kg, were anesthetized with 
sodium phenobarbital (30 mg/kg body weight intravenously), 
intubated and placed on a Harvard respirator. An occlusive 
thrombus was produced using the method described by 
Ritchie et al. (19). Both femoral arteries were surgically 
exposed. A 3 to 5 cm segmental injury was achieved by 
abrading the endothelium with a 5F balloon-tipped Swan- 
Ganz catheter and crushing the artery with forceps. The 
distal and proximal ends of the injured segments were 
temporarily ligated. Thrombin (15 NIH units, Thrombin 
Reagent, Merz-Dade) was injected into the occluded seg- 
ments. Stainless steel needles inserted into the tissue adja- 
cent to the ligature sites served as markers for identifying 
and defining the thrombotic obstruction during sonication. 
The trapped blood was allowed to coagulate for 120 min. A 
5F vascular Teflon sheath was introduced into the femoral 
arteries 15 to 20 cm distal to the site of obstruction. After the 
ligatures were released, arterial obstruction was cineangio- 
graphically verified by hand injections of contrast material. 
Ultrasound recanalization. Recanalization wus then at- 
tempted with the ultrasonic angioplasty device. In all the 
dogs, the right femoral artery served as the test artery and 
the left femoral artery served as the control artery. In the 
test arteries (n =z 7), the ultrasound wire was introduced 
through the vascular sheath under fluoroscopic guidance, 
with the distal tip I cm beyond the site of occlusion. 
Ultrasound (power 20 + 10 W) was then applied for 2 min. 
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During sonication, the ultrasound wire was moved back and 
forth between the vascular markers one or two times. 
Ultrasound was applied only when the distal tip was posi- 
tioned in the segment between the vascular markers. After 
application of ultrasound, recanalization was evaluated cine- 
angiographically by hand injections of contrast material. In 
the control arteries (n = 6), an identical procedure was 
followed. but without application of ultrasound. Percent 
stenosis was measured in each femoral arteriogram by 
caliper determination, comparing the most stenotic part of 
the obstructed segment with a proximal control segment. All 
arteriograms were read by two arteriographers who did not 
know of other study data. When they disagreed, a decision 
was reached by consensus and joint review of films. 
Pathologic examination. The animals were killed immedi- 
ately. Arterial segments were removed and placed in 10% 
neutral formalin. After fixation, 2 mm serial cross sections of 
the arterial segments were embedded in paraffin, and 5 pm 
sections were stained with hematoxylin-eosin and studied 
for extent and nature of injury in the test and control arterial 
segments. For the purpose of detailed analysis of arterial 
wall injury, the circumference of each arterial cross section 
was divided into four equal segments, and each segment was 
evaluated for the presence and nature of the arterial wall 
injury. The degree of arterial wall injury was evaluated 
similarly to the method of Kohchi et al. (20). A number that 
corresponded to the maxima1 depth of the arterial wall injury 
was assigned to each segment (0 = normal, I = intimal 
injury , 2 = media1 injury, 3 = adventitial injury). The arterial 
wall injury index was then obtained by summing the assigned 
numbers of each segment. 
Statistical analysis. All values are 
values -C SD. The mean values were 
unpaired Student’s t test. 
Results 
In Vitro Ultrasound Disruption 
expressed as mean 
compared using the 
Studies 
Atherosclerotic plaque disruption. On gross examination, 
atherosclerotic plaques exhibited a significant reduction in 
size after sonication. Their susceptibility to ultrasound 
changed with their morphology. Atheromatous plaques dis- 
rupted at a rate of 21 t 8 s/cm’; complicated plaques 
disrupted at a rate of 132 + 45 s/cm’ (p < 0.001). Athero- 
matous plaques disrupted almost completely with only a 
minimal rim of residual plaque, whereas with the compli- 
cated plaques, a larger rim consisting of heavily calcified 
tissue remained in situ. No perforation was observed in 
either the atherosclerotic or the control sonicated arterial 
segments. 
Histologic examination of the sonicated atherosclerotic 
segments revealed three distinct zones (Fig. 2). Zone 1 was 
a central vacant area with a smooth surface at the site of the 
disrupted plaque. Zone 2 was a rim of residual plaque at the 
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Figure 2. Representative histologic section (top) and drawing (bot- 
tom) of a atheromatous plaque disrupted by the ultrasound angio- 
plasty device. Three distinct zones are revealed: 1 = a central 
vacant area at the site of the disrupted plaque; 2 = a zone of residual 
plaque that appears somewhat vacuolated, perhaps secondary to 
acoustic effects of the ultrasound; and 3 = undamaged underlying 
arterial wall. 
periphery of the central vacant area. Zone 3 was a normal 
arterial wall adjacent to and underlying the disrupted plaque. 
Sonication did not affect the fiber and cellular architecture of 
the media or adventitia. All the control arterial segments 
showed endothelial denudation at the site of sonication, with 
no injury to the internal elastic lamina, media or adventitia. 
Here, too, sonication did not affect the fiber and cellular 
architecture of the media or adventitia. Neither the test nor 
the control segments exhibited evidence of thermal injury, 
blast damage or perforation. 
Microscopic analysis of the disrupted atheromatous 
plaque debris revealed rhomboid crystals with interfacial 
angles of 80”, consistent with cholesterol monohydrate crys- 
tals and amorphous calcified fragments. Ninety percent of 
the plaque debris particles were ~20 pm in diameter; several 
larger particles (5800 pm) were observed. 
Thrombus disruption. After sonication the weight of the 
thrombi was reduced from 1.6 ‘_’ 0.2 to 0.4 f 0.1 g (p < 
0.0001) and after mechanical penetration the weight was 
reduced from 1.5 ? 0.1 to 1.3 t 0.1 g (p < O.Ol), for mean 
100 
a9 90 
g 80 
5 2 70 
$ 60 
$ 
50 
& 
w 40 
& 
a 30 
2 
8 
20 
5 IO 
L 
0 I-- 
* . 
I I I 0 
before after before after 
WITH WITHOUT 
SONIFICATION SONIFICATION 
Figure 3. Ultrasound recanalization of occluded canine femoral 
arteries. In the test group (n = 7) (left), sonication resulted in 
recanalization in all arteries. The obstruction was reduced from 93 4 
11% to 18 k 7% (p < 0.001). In the control arteries (n = 5) (right), 
mechanical penetration without sonication reduced the degree of 
obstruction from 60% to 40% in only one artery. 
reductions of 77 k 5% and 16 ? 6%, respectively (p < 
0.001). Microscopic examination of the supernatant from the 
disrupted thrombi revealed the presence of one to five fibrin 
fragments per high power field (x400); no morphologic 
damage to the red blood cells was evident. The levels of 
fibrin degradation products were >128 &ml. The superna- 
tants of the disrupted thrombi did not recoagulate after 60 
min. 
In Vivo Ultrasound Recanalization Studies 
Recanalization. Ultrasound recanalization was attempted 
under conditions of total occlusion (n = 3) and high grade 
obstruction (n = 4) (Fig. 3). After sonication, a.high degree 
of recanalization was achieved in all test arteries. The 
obstruction was reduced from 93 IL 11% to 18 f 7% (p < 
0.001) (Fig. 4 and 5). Mechanical penetration of the six 
control arteries, two with complete occlusion and four with 
high grade obstruction, did not alter the degree of obstruc- 
tion in four arteries. In one artery, the degree of obstruction 
was reduced from 60% to 40%. One control artery was 
perforated by the ultrasound wire during attempted mechan- 
ical recanalization. 
Histology. From histologic examination, the arterial wall 
injury index wqs noted-to be 1.56 + 0.42 in the test arteries 
compared with 1.37 k 0.47 in the control arteries (p = NS). 
Sonicated test arteries did not exhibit evidence of thermal 
injury, blast damage or perforation (Fig. 6). 
Discussion 
Balloon angioplasty is currently the reference standard 
for the percutaneous management of arterial obstructive 
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Figure 4. A, Femoral arteriogram; retrograde injection of contrast 
material shows an experimentally induced total occlusion. Arrows 
indicate the vascular markers inserted to identify and define the 
occluded segment during sonication. B, Restoration of lumen diam- 
eter after sonication for 2 min with the ultrasonic angioplasty device. 
Note a residual minimal residual filling defect. 
disease, with a primary success rate approaching 90% to 
95% in coronary arteries. However, limitations exist. Abrupt 
arterial closure secondary to dissection requires the avail- 
ability of bypass surgery. Restenosis occurs at a rate of 20% 
to 49% in coronary arteries with current balloon angioplasty 
systems. Another major limitation is the low rate of primary 
success in chronic, totally occluded vessels. The lack of 
reliable techniques to maintain distal perfusion after abrupt 
arterial closure and the inability to reach, cross and dilate 
distal lesions in tortuous vessels further limit balloon tech- 
nology (2 l-24). 
These disadvantages have stimulated the explosion of 
new devices, including lasers, atherectomy devices and 
vascular stents designed to overcome the current limitations 
of balloon angioplasty. Although these devices may repre- 
sent an improvement, the reality at this time is that most 
offer only a hypothetical advantage. All suffer from signifi- 
cant limitations principally related to the induction of uncon- 
trolled injury to the artery (25-28). 
Results of ultrasonic angioplasty. We developed and stud- 
ied an ultrasonic angioplasty device capable of guiding high 
energy ultrasound in a flexible delivery system. The device 
was studied in two bioassay systems: an in vitro system for 
Figure 5. A, Femoral arteriogram: retrograde injection of contrast 
material shows an experimentally induced high grade extensive 
thrombotic obstruction. Arrows indicate the vascular markers in- 
serted to identify and define the obstructed segment during sonica- 
tion. B, Restoration of lumen diameter between the vascular mark- 
ers after sonication for 2 min with the ultrasonic angioplasty device. 
Note the persistence of the obstruction proximal to the vascular 
markers where ultrasound was not applied. 
the disruption of atherosclerotic plaques and thrombi and an 
in vivo system for the recanalization of occluded canine 
femoral arteries. In vitro, the ultrasonic angioplasty device 
effectively disrupted plaques and thrombi. Atheromatous 
plaques were found to be significantly more susceptible to 
ultrasound than complicated plaques. Histologic studies of 
sonicated arterial segments indicate that the device disrupts 
atherosclerotic plaques with only minimal damage to the 
adjacent arterial wall. The presence of abundant fibrin 
fragments and the absence of change in the morphology of 
the red blood cells in the supernatant from the disrupted 
thrombi suggest that the mechanism of ultrasound thrombus 
disruption is damage to the fibrin matrix. In vivo, a signifi- 
cant high degree of recanalization was achieved in all the 
sonicated arteries. The same extent and nature of injury 
found in both the sonicated and the control arteries indicate 
that the injury was a by product of the method employed to 
obtain stable arterial occlusive thrombi in vivo. 
The in vitro disruption of atherosclerotic plaques and 
thrombi, together with the efficient in vivo recanalization of 
the obstructed arteries, demonstrates the ability of the 
ultrasonic angioplasty device to transmit sufficient ultra- 
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Figure 6. Histologic study of the canine femoral artery shown in 
Figure 4B. The test and control arteries exhibited the same extent 
and nature of injury (arrows). This finding may indicate that the 
injury is a by-product of the method used to obtain stable occlusive 
arterial thrombus. 
sound for it to have a potential use in angioplasty. The 
different rates of disruption of thrombi and atheromatous 
and complicated plaques suggest that energy requirements 
for ultrasonic angioplasty might depend on the relative 
composition of thrombus, fatty fibrous and calcific elements 
in the arterial obstruction. Histologic data suggest that this 
device selectively disrupts the ultrasound-sensitive plaques 
and thrombi, with minimal damage to the ultrasound- 
resistant arterial wall. 
Previous studies. Our results are consistent with the 
recent demonstration of effective in vitro ultrasonic plaque 
disruption by Siegel et al. (29). Contrary to their findings, 
none of our sonicated tissue samples displayed thermal 
injury, even after prolonged (240 s) exposure to ultrasound. 
Ultrasound conversion to heat in the transmission wire is a 
problem encountered in other high energy ultrasound medi- 
cal devices, and the need for adequate cooling is known 
(12,13). In fact, thermal injury of tissue from exposure to 
high energy ultrasound in the 20 kHz range has never been 
described (12-15). Thus, the thermal injury and associated 
perforations described by Siegel et al. (29) may not have 
been due to the primary effect of ultrasound, but rather may 
have been a secondary effect resulting from the conversion 
of ultrasound to heat in the ultrasound transmission wire. 
Mechanisms. The mechanism of hand-held ultrasound 
surgical devices is believed to be a result of mechanical 
fragmentation (12-15). The strokes of the ultrasound probe 
are directly responsible for the fragmentation processes in 
the contact plane between the ultrasound probe and the 
target tissue. Cavitational effect has been implicated as the 
mechanism of ultrasound tissue disruptors (9-11). High 
energy ultrasound applied to liquids generates vapor-filled 
microbubbles, or “cavities.” The rapid expansion and col- 
lapse of the cavities are accompanied by local intense 
hydraulic shocks in the surrounding liquid, leading to the 
disruption of the target tissue. We believe that the mecha- 
nisms responsible for ultrasonic angioplasty are similar. 
Both mechanical and cavitational effects are probably im- 
portant in the disruption of atherosclerotic plaques and 
thrombi. 
Study limitations. The debris of the disrupted atheroma- 
tous plaques was found to be composed mainly of choles- 
terol monohydrate crystals. Although 90% of the debris 
particles had dimensions ~20 pm, several larger particles 
were observed. The quantity and size distribution of the 
debris resulting from ultrasonic angioplasty and their poten- 
tial adverse effects on distal circulation were not investigated 
in our study. Debris particles in the size range we noted have 
been produced by some mechanical atherectomy devices, 
but data on their effect on distal circulation are controversial 
(30,31). Our observations on the size of the sonicated plaque 
debris indicate that its effect on distal circulation warrants 
further study. Refinements of the ultrasound angioplasty 
device that will permit either aspiration of the debris parti- 
cles or reduction of debris particle size to subcapillary 
dimensions may have to be developed. 
Conclusion. The potential advantage of ultrasonic angio- 
plasty over other angioplasty techniques derives from the 
inherent ability of ultrasound to exploit differences in acous- 
tic impedance between the arterial wall and the obstructive 
plaque-thrombus complex. Thus, a desired controlled injury 
to the artery can be induced; the luminal obstruction can be 
disrupted without damaging the integrity of the arterial wall. 
As a result, neither precise coaxiality of the ultrasound wire 
nor power application time during the experimental ultra- 
sonic angioplasty was crucial because slight errors did not 
damage the arterial wall. These unique qualities demonstrate 
the promise of ultrasonic angioplasty as a catheter-based 
interventional technique for arterial obstructive diseases. 
We thank Paul J. Cannon, MD and Andrew M. Keller, MD for their insight, 
criticism and valuable advice. 
References 
1. Gruentzig AR. Transluminal dilatation of coronary artery stenosis. Lan- 
cet 1978;1:263. 
2. Gruentzig AR, Senning A, Siegenthalaer WE. Nonoperative dilatation of 
coronary artery stenosis: percutaneous transluminal coronary angio- 
plasty. N Engl J Med 1979;301:61-8. 
3. Sigwart U, Paul J, Merkowitch V, Joffre F, Kappenberer L. Intravascular 
stents to prevent occlusion and restenosis after transluminal angioplasty. 
N Engl J Med 1987;316:701-6. 
4. Abela GS, Seeger JM, Barbieri E, et al. Laser angioplasty with angio- 
scopic guidance in humans. J Am Coil Cardiol 1986;8:184-92. 
JACC Vol. 15. No. 3 ROSENSCHEIN ET AL. 717 
March I. 199Q711-7 EXPERIMENTAL ULTRASONIC ANGIOPLASTY 
5. Sanborn TA. Bonan R, Cumberland DC, et al. Percutaneous coronary 
laser assisted balloon angioplasty with flexible, central lumen laser probe 
catheters (abstr). Circulation 1988:78(suppl II):Il-293. 
6. Simpson JB, Selmon MR. Robertson GC, et al. Transluminal atherectomy 
for occlusive peripheral vascular disease. Am J Cardiol 1988;61:96G- 
IOIG. 
7. Simpson JB, Gregory C, Robertson M, Selmon R. Percutaneous coronary 
atherectomy (abstr). Circulation 1988;78(suppl II):II-82. 
8. Katzen BT. Schwarten DM, Kaplan JO, Cutcliff W. Initial experience 
with an excimer laser in peripheral lesions (abstr). Circulation 1988: 
78(suppl Il):II-417. 
9. Todd JH. Measurement of chemical activity of ultrasonic cavitation in 
aqueous solutions. Ultrasonics 1970;8:234-9. 
10. Skauen DM. A comparison of heat production and cavitational intensity 
in several ultrasonic cell disruptors. Ultrasonics 1975:14:173-6. 
Il. Rooney JA. Hemolysis near an ultrasonically pulsating gas bubble. 
Science 1970;169:869-71. 
12. Marberger M. Disintegration of renal and urethral calculi with ultrasound. 
Urol Clin North Am 1983;10:729-41. 
13. Hodgson WJB, Poddar PK, Mencer EJ, Williams J, Drew M, McElhinney 
AJ. Evaluation of ultrasonically powered instruments in the laboratory 
and in the clinical setting. Am J Gastroenterol 1979:72:133-40. 
14. Mowry R, Hengerer AS. The ultrasonic scalpel in head and neck surgery. 
Otolaryngol Head Neck Surg 1982;90:305-8. 
15. Brown AH. Davies PG. Ultrasonic decalcification of calcified cardiac 
valves and annuli. Br Med J 1972;143:1088-9. 
16. Blankenhorn DH, Kramsch DM. Reversal of atherosis and sclerosis: the 
two components of atherosclerosis. Circulation 1989:79: l-7. 
17. Rokosova B, Rapp JH, Porter JM, Bentley JP. Composition and metab- 
olism of symptomatic distal aortic plaque. J Vast Surg 1986:3:617-22. 
18. Robbins SL. Cotran RS. Kumar V. Pathologic Basis of Disease. 3rd ed. 
Philadelphia: WB Saunders, 1984:509-13. 
19. Ritchie JL, Hansen DD, Vraco R. Auth DC. Mechanical thrombolysis: a 
new rotational catheter approach for acute thrombi. Circulation 1986:73: 
1006-12. 
20. Kohchi K, Shigeo T, Block PC, Hiroki T. Nobuyoshi M. Arterial changes 
after percutaneous transluminal coronary angioplasty: results at autopsy. 
J Am Coll Cardiol 1987;10:592-9. 
21. Bourassa MG. Alderman EL, Bertrand M, et al. Report of the joint 
ISFCiWHO Task Force on coronary angioplasty. Circulation 1988;78: 
780-9. 
22. Levine S. Ewels CJ. Rosing DR, Kent KM. Coronary angioplasty: 
clinical and angiographic follow-up. Am J Cardiol 1985;55:673-6. 
23. Vandormael MG, Deligonus U. Kern MJ. et al. Studies in coronary 
revascularization: multilesion coronary angioplasty-clinical and angio- 
graphic follow-up. J Am Coil Cardiol 1987;10:246-52. 
24. Detre K, Holubkov R. Kelsey S, et al. Percutaneous transluminal 
coronary angioplasty in 1985-1986 and 1977-1981: the National Heart, 
Lung. and Blood Institute Registry. N Engl J Med 1988;318:265-70. 
25. Katzen BT. Current status of peripheral PTA: the role of new devices. 
Circulation 1988:78(suppl 11):11-D. 
26. Forrester JS. Laser angioplasty. now and in the future. Circulation 
19X8:78:777-9. 
27. Ginsburg R, Jenkins N, Wright A, Wexler L, McGowan L, Mehigan J. 
Transluminal peripheral vessel angioplasty: clinical experience with new 
therapeutic devices (abstr). Circulation 1988:78(suppl II):II-270. 
28. Lee G. Ekeda RM. Chan MC, et al. Limitations, risks, and complications 
of laser recanalization: a cautious approach warranted. Am J Cardiol 
1985:56:181-5. 
29. Siegel RJ. Fishbein NC, Forrester J, et al. Ultrasonic plaque ablation, a 
new method for recanalization of partially occluded arteries. Circulation 
1988:78:1443-8. 
30. Zacca NM, Raizner AE, Noon GP, et al. Short term follow up of patients 
treated with a recently developed rotational atherectomy device and in 
vivo assessment of the particles generated (abstr). J Am Coll Cardiol 
1988:ll(suppl A):l09A. 
31. Prevosti LG. Cook JA, Unger EF, et al. Particulate debris from rotational 
atherectomy: size distribution and physiologic effects (abstr). Circulation 
1988:78(suppl II):II-83. 
